Clinical Trial Update: Psychosomatic Effects of Implantable Cardioverter Defibrillator With Home Monitoring Function (QUANTUM) [NA]

View source ↗

Summary

Clinical trial update on psychosomatic effects of an implantable cardioverter defibrillator with home monitoring (QUANTUM); the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia

Snippet

Sponsor: Biotronik SE & Co. KG | Conditions: Arrhythmia, Quality of Life | NA | Status: COMPLETED